Showing 1-10 of 20 results for "".

• Significant FDA Approval for PDT

  https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/
  Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.
  • Video
  • Audio
  • Transcript

• Jonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition

  https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/
  Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to u
  • Video
• Jonathan Weiss, MD
  https://practicaldermatology.com/profiles/jonathan-weiss-md/jG8En9/
• Jonathan S. Weiss, MD
  https://practicaldermatology.com/profiles/jonathan-s-weiss-md/L6Gogv/
  Dr. Jonathan Weiss joined Gwinnett Dermatology, P.C. and Gwinnett Clinical Research Center in 1991. He has active clinical and research interests in psoriasis, topical and systemic retinoids, photodamage, actinic keratosis, skin cancer, rosacea, infectious disease, and cosmetic dermatology. Dr. W…

• Physician Spotlight: Stefan Weiss, MD

  https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-stefan-weiss-md/24017/
  From enhancing the diagnosis and treatment of skin diseases to identifying unmet clinical needs, artificial intelligence (AI) and big data are upending the practice of dermatology.
  • Text

• Inside LEVEL UP: Lead Investigator Discusses Upadacitinib Study

  https://practicaldermatology.com/topics/atopic-dermatitis/inside-level-lead-investigator-discusses-upadacitinib-study/26661/
  Inside LEVEL UP: Lead Investigator Discusses Upadacitinib Study
  • Text
• Vial Dermatology CRO adds Dr. Jonathan Zung to Scientific Advisory Board
  https://practicaldermatology.com/news/vial-dermatology-cro-adds-dr-jonathan-zung-to-scientific-advisory-boar/2461236/
  The Vial Dermatology CRO welcomed Jonathan Zung, PhD, as the newest addition to the Vial Scientific Advisory Board. Dr. Zung will support the Vial CRO team and their sponsors to further advance the field of dermatology clinical researc
• Special Report: An Overview of Coronavirus by Dr. Jonathan Kaplan
  https://practicaldermatology.com/news/special-report-an-overview-of-coronavirus-by-dr-jonathan-kaplan/2460306/
  Wash your hands, wipe down surfaces, don’t touch your face, and practice social distancing. If nothing else, that’s what you should take away from this coronavirus overview. But keep reading to learn important details about this epidemic. Such as, how we can make it end with less coll
• Beyond the Headlines: Dr. Jonathan Silverberg Reviews Maintenance Data on Rademikibart From a Pivotal Trial in China
  https://practicaldermatology.com/news/beyond-the-headlines-dr-jonathan-silverberg-reviews-maintenance-data-on-rademikibart-from-a-pivotal-trial-in-china/2462152/
  DermWire recently reported positive topline results from a 52-week maintenance study of rademikibart in people with atopic dermatitis (AD).  At
• Jan Marini Skin Research Marks 20 Years of Innovation
  https://practicaldermatology.com/news/20140625-jan_marini_skin_research_marks_20_years_of_innovation/2459188/
  After 20 years, Jan Marini Skin Research (JMSR) continues to distinguish itself as a recognized leader in the professional skincare industry through its combined focus on results, new productinnovation and its commitment to clinical and medical validation. Robert Weiss, MD, conducted a st

• Prev
• 1
• 2
• Next